These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 11539926)

  • 1. Transmembrane transport of peptide type compounds: prospects for oral delivery.
    Lipka E; Crison J; Amidon GL
    J Control Release; 1996 May; 39(2-3):121-9. PubMed ID: 11539926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in protein and peptide drug delivery systems.
    Malik DK; Baboota S; Ahuja A; Hasan S; Ali J
    Curr Drug Deliv; 2007 Apr; 4(2):141-51. PubMed ID: 17456033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral peptide delivery: Translational challenges due to physiological effects.
    Tyagi P; Pechenov S; Anand Subramony J
    J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral peptide and protein delivery: intestinal obstacles and commercial prospects.
    Smart AL; Gaisford S; Basit AW
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1323-35. PubMed ID: 24816134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodrug approaches to the improved delivery of peptide drugs.
    Wang W; Jiang J; Ballard CE; Wang B
    Curr Pharm Des; 1999 Apr; 5(4):265-87. PubMed ID: 10101225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs.
    Yamamoto A; Ukai H; Morishita M; Katsumi H
    Pharmacol Ther; 2020 Jul; 211():107537. PubMed ID: 32201316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
    Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
    Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
    Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
    Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging trends in oral delivery of peptide and protein drugs.
    Mahato RI; Narang AS; Thoma L; Miller DD
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):153-214. PubMed ID: 14584523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Delivery system design for improvement of intestinal absorption of peptide drugs].
    Muranishi S
    Yakugaku Zasshi; 1997 Jul; 117(7):394-414. PubMed ID: 9261212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery.
    Bai JP; Amidon GL
    Pharm Res; 1992 Aug; 9(8):969-78. PubMed ID: 1409387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral controlled release technology for peptides: status and future prospects.
    Fix JA
    Pharm Res; 1996 Dec; 13(12):1760-4. PubMed ID: 8987068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
    Yamamoto A
    Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of peptides and proteins using lipid-based drug delivery systems.
    Li P; Nielsen HM; Müllertz A
    Expert Opin Drug Deliv; 2012 Oct; 9(10):1289-304. PubMed ID: 22897647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer-based oral peptide nanomedicines.
    Herrero EP; Alonso MJ; Csaba N
    Ther Deliv; 2012 May; 3(5):657-68. PubMed ID: 22834409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery.
    Leonaviciute G; Bernkop-Schnürch A
    Expert Opin Drug Deliv; 2015; 12(11):1703-16. PubMed ID: 26477549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches.
    Brayden DJ; Hill TA; Fairlie DP; Maher S; Mrsny RJ
    Adv Drug Deliv Rev; 2020; 157():2-36. PubMed ID: 32479930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral delivery of peptide drugs: barriers and developments.
    Hamman JH; Enslin GM; Kotzé AF
    BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.